SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
PTIX

Protagenic Therapeutics, Inc. ew (OTC:PTIX)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$0.38-$0.04 (-9.52%)
 
Market cap
$688K
Insider Score
Health Score
Analyst consensus
Listed since
Apr 27, 2021
Market Cap$687.88K-83.3%
Revenue (ttm)$0+100.0%
Net Income$5.66M+163.5%
EPS$3.05+163.1%
Shares Out1.81M
PE Ratio0.12
Forward PEn/a
Dividendn/a
Ex-Dividend DateDec 5, 2005
Volume15,513
Open$0.40
Previous Close$0.42
Day's Range$0.35 - $0.48
52-Week Range$0.13 - $2.38
Beta1.07
AnalystsBuy
Price Targetn/a
Earnings DateMar 3, 2027
-9.52% (1D)
No price history available.

About PTIX

Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.

Address
149 Fifth Avenue, New York, NY, 10010, US
Market Cap
1 million
Employees
2
Industrial Classification
Biotechnology

Protagenic Therapeutics, Inc. ew Stock Analysis — InsiderScore

Insider Score
See top-rated InsiderScore stocks ›
37th Percentile Overall Score
PTIX InsiderScore:63 / 99

Protagenic Therapeutics, Inc. ew scored higher than 37% of companies evaluated by InsiderBuying, and ranked 46th out of 99 stocks in the biotech sector.

Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.

Dollars Committed

Insiders at Protagenic Therapeutics, Inc. ew bought $23.8K of stock across 3 purchases in the last 90 days, the largest of them $13.0K.

Stake Increase

The average purchase added about 30% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.

New Positions

Every buyer already held stock, so each purchase is an increase rather than a first position.

This category carries 35% of the Insider Score.

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$30.72K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Weak
From PTIX’s reported statements · Q3 2026 (trailing 12 months) · 4 of 5 pillars

Next catalysts

1 Day
-9.52%
5 Days
-15.56%
1 Month
-48.30%
6 Months
-38.51%
1 Year
-83.26%

$PTIX stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in PTIX holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by PTIX's directors and management

Net Shares Purchased by Insiders−80k−40k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

PTIX Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New PTIX patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to PTIX from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from PTIX’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
100% of score
67.84
Analyst Ratings
No data yet
—
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
7
Sells
0
Buy Value
$30.72K
Distinct Buyers
1

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.